Clinical Trial Update: Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Tolecizumab in combination with chemoimmunotherapy for pMMR/MSS locally advanced colon adenocarcinoma. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenocarcinoma

Drugs mentioned

• Tolecizumab (tolecizumab)

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Colon Adenocarcinoma | Phase 2 | Status: RECRUITING